Compare · HNGE vs LFMD
HNGE vs LFMD
Side-by-side comparison of Hinge Health Inc. (HNGE) and LifeMD Inc. (LFMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- HNGE operates in Technology, while LFMD operates in Health Care - the two are in different parts of the market.
- HNGE is the larger of the two at $8.79B, about 113.6x LFMD ($77.3M).
- HNGE has been more active in the news (10 items in the past 4 weeks vs 6 for LFMD).
- HNGE has more recent analyst coverage (16 ratings vs 12 for LFMD).
- Company
- Hinge Health Inc.
- LifeMD Inc.
- Price
- -
- -
- Market cap
- $8.79B
- $77.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- EDP Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 10
- 6
- Recent ratings
- 16
- 12
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Latest HNGE
- Director Robinson Elliott sold 0 shares (SEC Form 4)
- Exec. Chairman & Co-Founder Mecklenburg Gabriel M.I. converted options into 200,000 shares and sold $24,482,097 worth of shares (200,000 units at $122.41) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Financial Officer Budge James sold $4,367,052 worth of shares (35,907 units at $121.62) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 256,207 units (SEC Form 4)
- SEC Form 144 filed by Hinge Health Inc.
- SEC Form 10-Q filed by Hinge Health Inc.
- Director Robinson Elliott sold 0 shares (SEC Form 4)
- Chief Financial Officer Budge James covered exercise/tax liability with 4,614 shares, decreasing direct ownership by 2% to 292,114 units (SEC Form 4) (for withholding tax)
- President Pursley James covered exercise/tax liability with 831 shares, decreasing direct ownership by 0.12% to 665,247 units (SEC Form 4) (tax withholding)
- Hinge Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Hinge Health reports record third quarter 2026 financial results
Latest LFMD
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- LifeMD Reports Third Quarter 2026 Results
- SEC Form NT 10-Q filed by LifeMD Inc.
- LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
- LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide
- LifeMD to Report Third Quarter 2026 Financial Results on November 9
- SEC Form S-8 filed by LifeMD Inc.
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
- LifeMD Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits